Association of rs2046210 and rs12662670 with risk of ER−*/ER+** breast cancer.

Results are presented overall as well as separately for Europeans and Asians. Pooled analyses adjusted for the studies were performed. A log-additive genetic model was assumed.*Estrogen receptor negative.**Estrogen receptor positive.aOdds ratio per minor allele (A allele for rs2046210, G allele for rs12662670) derived from case-control logistic regression restricted to ER+ or ER− cases, respectively, and the whole control sample.bP-value derived from the log-additive model derived from case-control logistic regression restricted to ER+ or ER− cases, respectively, and the whole control sample.cP-value for heterogeneity between estimates of genetic main effects derived from case-only analysis.